North of England evidence based development project: guideline for angiotensin converting enzyme inhibitors in primary care management of adults with symptomatic heart failure.
作者信息
Eccles M, Freemantle N, Mason J
机构信息
Centre for Health Services Research, University of Newcastle upon Tyne, Newcastle upon Tyne NE2 4AA.
出版信息
BMJ. 1998 May 2;316(7141):1369-75. doi: 10.1136/bmj.316.7141.1369.
Abstract
摘要
相似文献
1
North of England evidence based development project: guideline for angiotensin converting enzyme inhibitors in primary care management of adults with symptomatic heart failure.英格兰北部循证发展项目：成人症状性心力衰竭初级护理管理中血管紧张素转换酶抑制剂指南
BMJ. 1998 May 2;316(7141):1369-75. doi: 10.1136/bmj.316.7141.1369.
2
Cost-effective management of heart failure.
Clin Cardiol. 1996 Mar;19(3):240-2. doi: 10.1002/clc.4960190319.
3
Cost of heart failure to the healthcare system.
Am J Manag Care. 1998 Jun;4(6 Suppl):S338-42.
4
The role of ACE inhibitors in mild heart failure.
Practitioner. 1994 Jan;238(1534):66-9.
5
Heart failure. New treatment options.
Aust Fam Physician. 1996 Jul;25(7):1035, 1038-43.
6
7
Safety and costs of initiating angiotensin converting enzyme inhibitors for heart failure in primary care: analysis of individual patient data from studies of left ventricular dysfunction.基层医疗中起始使用血管紧张素转换酶抑制剂治疗心力衰竭的安全性和成本：来自左心室功能障碍研究的个体患者数据分析
BMJ. 2000 Nov 4;321(7269):1113-6. doi: 10.1136/bmj.321.7269.1113.
8
Taking heart failure seriously.认真对待心力衰竭。
BMJ. 2000 Nov 4;321(7269):1095-6. doi: 10.1136/bmj.321.7269.1095.
9
10
ABC of heart failure. Management: diuretics, ACE inhibitors, and nitrates.心力衰竭基础知识。治疗：利尿剂、血管紧张素转换酶抑制剂及硝酸盐类药物。
BMJ. 2000 Feb 12;320(7232):428-31. doi: 10.1136/bmj.320.7232.428.
引用本文的文献
1
Adherence to biochemical monitoring recommendations in patients starting with renin angiotensin system inhibitors: a retrospective cohort study in the Netherlands.开始使用肾素-血管紧张素系统抑制剂的患者中对生化监测建议的依从性：荷兰的一项回顾性队列研究。
Drug Saf. 2011 Jul 1;34(7):605-14. doi: 10.2165/11587250-000000000-00000.
2
Role of the angiotensin II receptor blocker valsartan in heart failure.血管紧张素II受体阻滞剂缬沙坦在心力衰竭中的作用
Exp Clin Cardiol. 2001 Winter;6(4):215-21.
3
Differential associations between actual and expected GP practice prescribing rates for statins, ACE inhibitors, and beta-blockers: a cross-sectional study in England.实际和预期的全科医生处方他汀类药物、ACE 抑制剂和β受体阻滞剂的比率之间的差异关联：英格兰的一项横断面研究。
Ther Clin Risk Manag. 2005 Mar;1(1):61-8. doi: 10.2147/tcrm.1.1.61.53599.
4
Best practice in primary care pathology: review 6.基层医疗病理学的最佳实践：综述6
J Clin Pathol. 2007 Mar;60(3):225-34. doi: 10.1136/jcp.2006.040014. Epub 2006 Jul 5.
5
Management of chronic heart failure: perceived needs of general practitioners in light of the new general medical services contract.慢性心力衰竭的管理：鉴于新的全科医疗服务合同，全科医生的感知需求
Postgrad Med J. 2005 May;81(955):321-6. doi: 10.1136/pgmj.2004.022947.
6
Methodology for constructing guidance.构建指南的方法学。
J Clin Pathol. 2005 Mar;58(3):249-53. doi: 10.1136/jcp.2004.018374.
7
Adverse effects of ACE inhibitors in patients with chronic heart failure and/or ventricular dysfunction : meta-analysis of randomised clinical trials.血管紧张素转换酶抑制剂对慢性心力衰竭和/或心室功能障碍患者的不良反应：随机临床试验的荟萃分析
Drug Saf. 2003;26(12):895-908. doi: 10.2165/00002018-200326120-00004.
8
Clinical practice guidelines: towards better quality guidelines and increased international collaboration.临床实践指南：迈向更高质量的指南及加强国际合作。
Br J Cancer. 2003 Aug;89 Suppl 1(Suppl 1):S4-8. doi: 10.1038/sj.bjc.6601077.
9
10
Quinapril: a further update of its pharmacology and therapeutic use in cardiovascular disorders.喹那普利：其在心血管疾病中的药理学及治疗应用的进一步更新
Drugs. 2002;62(2):339-85. doi: 10.2165/00003495-200262020-00009.
本文引用的文献
1
North of England evidence based guidelines development project: methods of developing guidelines for efficient drug use in primary care.英格兰北部循证指南制定项目：制定基层医疗中高效用药指南的方法
BMJ. 1998 Apr 18;316(7139):1232-5. doi: 10.1136/bmj.316.7139.1232.
2
Use of Irwin's restricted mean as an index for comparing survival in different treatment groups--interpretation and power considerations.将欧文受限均值用作比较不同治疗组生存率的指标——解读与效能考量
Control Clin Trials. 1997 Apr;18(2):151-67. doi: 10.1016/s0197-2456(96)00089-x.
3
Prevalence, aetiology and management of heart failure in general practice.全科医疗中心力衰竭的患病率、病因及管理
Br J Gen Pract. 1996 Feb;46(403):77-9.
4
Czech and Slovak spirapril intervention study (CASSIS). A randomized, placebo and active-controlled, double-blind multicentre trial in patients with congestive heart failure.捷克和斯洛伐克螺普利干预研究（CASSIS）。一项针对充血性心力衰竭患者的随机、安慰剂和活性对照、双盲多中心试验。
Eur J Clin Pharmacol. 1995;49(1-2):95-102. doi: 10.1007/BF00192366.
5
What is the ideal study design for evaluation of treatment for heart failure? Insights from trials assessing the effect of ACE inhibitors on exercise capacity.
Eur Heart J. 1996 Jan;17(1):120-34. doi: 10.1093/oxfordjournals.eurheartj.a014670.
6
A multicentre, double-blind, placebo-controlled trial of quinapril in mild, chronic heart failure.一项关于喹那普利治疗轻度慢性心力衰竭的多中心、双盲、安慰剂对照试验。
Eur Heart J. 1993 Mar;14(3):403-9. doi: 10.1093/eurheartj/14.3.403.
7
Effects of early use of captopril on haemodynamics and short-term ventricular remodelling in acute anterior myocardial infarction.
Eur Heart J. 1993 Feb;14(2):259-66. doi: 10.1093/eurheartj/14.2.259.
8
Echocardiography in chronic heart failure in the community.社区慢性心力衰竭的超声心动图检查
Q J Med. 1993 Jan;86(1):17-23.
9
Lisinopril lowers cardiac adrenergic drive and increases beta-receptor density in the failing human heart.赖诺普利可降低衰竭的人心脏中的心脏肾上腺素能驱动，并增加β受体密度。
Circulation. 1993 Aug;88(2):472-80. doi: 10.1161/01.cir.88.2.472.
10
Influence of angiotensin converting enzyme inhibition on exercise performance and clinical symptoms in chronic heart failure: a multicentre, double-blind, placebo-controlled trial.
Eur Heart J. 1993 Jul;14 Suppl C:18-23. doi: 10.1093/eurheartj/14.suppl_c.18.
Zotero 插件